Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia

• Egile Nagusiak: E. A. Orudzhova (Egilea), V. O. Bitsadze (Egilea), M. V. Tretyakova (Egilea), D. A. Doronicheva (Egilea), F. Yakubova (Egilea)
• Formatua: Liburua
• Argitaratua: IRBIS LLC, 2022-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Aim: to evaluate the effectiveness of using low molecular weight heparin (LMWH) and low-dose acetylsalicylic acid (ASA) in preventing recurrence of early and late fetal growth retardation (FGR) in patients with antiphospholipid syndrome (APS) and/or genetic thrombophilia.Materials and Methods. A pro...